(FC) Bioquímica y Genética
Departamento académico
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (11)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress
Cells, Vol. 12, Núm. 18
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Journal of Clinical Investigation, Vol. 131, Núm. 23
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
Genome Research, Vol. 30, Núm. 9, pp. 1217-1227
2010
-
Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall
Circulation, Vol. 121, Núm. 18, pp. 2033-2044
2008
-
Identification of a locus modulating serum C-reactive protein levels on chromosome 5p15
Atherosclerosis, Vol. 196, Núm. 2, pp. 863-870